Fresh research from McKinsey suggesting AI can create more roles than it replaces has pushed artificial intelligence back ...

Profound Medical Corp. entered into a co-education agreement with Telix Pharmaceuticals to educate physicians and prostate cancer centers on the complementary roles of their ...

Counties with greater proportions of non-Hispanic White residents had lower medical debt prevalence. Medical debt and cancer incidence were generally higher in the South and Southwest and lower in the ...

Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies ...

A retrospective analysis of 787 men found an MRI and AI rule could avoid 149 biopsies while retaining 98.4 per cent ...

Dr Imogen Brooks was left despairing around three years ago after surgery left her without most of her tongue - and ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today ...

Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...

Profound Medical Corp (NASDAQ:PROF) shares jumped almost 20% in after-hours trading Wednesday after the company raised its third quarter 2026 revenue guidance above Wall Street estimates.

Zenflow’s Spring implant, designed to treat the symptoms of benign prostatic hyperplasia (BPH), secured FDA clearance in December 2025.

September 30, 2026, 10:01 to October 7, 2026, 10:01 (JST)This week, progress was made in preparing for U.S. regulatory ...

Cook Medical has become Zenflow’s U.S. distributor in a urology device market targeted by Boston Scientific, Olympus and ...